| BMS-816336 |
BMS-816336 |
1009583-20-3 |
| 1-methyl-4-nitro-1H-pyrazole-5-carbonyl chloride |
2-甲基-4-硝基-3-吡唑甲酰氯 |
1006962-20-4 |
| TC ASK 10 |
化合物 T13099 |
1005775-56-3 |
| Takinib |
1111556-37-6 |
1111556-37-6 |
| TM 5275 |
CS-2524 |
1103926-82-4 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| TC-S 7005 |
TC-S 7005 |
1082739-92-1 |
| LY 367385 |
LY-367385;(R)-(+)-ALPHA-AMINO-4-CARBOXY-2-METHYLBENZENEACETIC ACID |
198419-91-9 |
| WYE-687 |
N-[4-[4-(4-吗啉基)-1-[1-(3-吡啶甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶-6-基]苯基]氨基甲酸甲酯 |
1062161-90-3 |
| WAY-600 |
6-(1H-吲哚-5-基)-4-(4-吗啉基)-1-[1-(3-吡啶基甲基)-4-哌啶基]-1H-吡唑并[3,4-D]嘧啶 |
1062159-35-6 |
| N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine |
N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 |
1063331-94-1 |
| Fosfluconazole |
福司氟康唑 |
194798-83-9 |
| Bedoradrine |
贝多拉君 |
194785-19-8 |
| CTS-1027 |
4-[[[4-(4-氯苯氧基)苯基]磺酰基]甲基]四氢-N-羟基-2H-吡喃-4-甲酰胺 |
193022-04-7 |
| trans-3-Aminocyclobutanol |
反式-3-氨基环丁醇 |
1036260-45-3 |
| 2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindo l-5-yl]acetic acid |
7-[(2,2-二甲基-1-氧代丙基)氨基]-2,3-二氢-4,6-二甲基-1-辛基-1H-吲哚-5-乙酸 |
189198-30-9 |
| TPO agonist 1 |
1033040-23-1 |
1033040-23-1 |
| Bimosiamose |
Bimosiamose |
187269-40-5 |
| GSK-626616 |
GSK-626616 |
1025821-33-3 |
| AMD 3465 (*Hexahydrobromide*) |
AMD 3465 |
185991-07-5 |
